Bausch + Lomb Corporation Common Shares (BLCO) Stock Forecast: StockMap's 2-Week Call
BLCO stock forecast: StockMap's model makes no two-week call on Bausch + Lomb Corporation Common Shares after the Nov 19 close: its evidence is split, 7 reasons for and 8 against. Too few two-week windows graded to judge yet.
Bausch + Lomb Corporation Common Shares last closed at $20.69, -1.24% on the session.
Against the IVW growth benchmark the position is +1.09% over the forecast window.
Bausch + Lomb Corporation Common Shares' market cap is $7.41B as of November 19, 2026.
No call today: the model sees no clear direction · the next 2 weeks, vs S&P 500 growth. The lean on a scale from −100 to +100 is -1 (too close to call).
Where BLCO sits: sized by market cap, coloured by the day's move.
The read is built from 15 underlying insights — 7 bullish and 8 bearish.
Agreement across those insights is 53%.
1 daily call for BLCO so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.
On the fundamentals StockMap ranks Bausch + Lomb Corporation Common Shares in the 38th percentile on return on equity, where 100 is best.
Bausch + Lomb Corporation Common Shares is classified under Health Care / Health Care Equipment & Supplies.
StockMap tracks Bausch + Lomb Corporation Common Shares as the 26th largest of the 141 companies it covers in the Health Care Equipment & Supplies industry, part of the Health Care sector.
Across that group the current two-week reads are 69 Neutral, 55 Moderate Underperform, 14 Strong Underperform and 3 Moderate Outperform.
On that composite Bausch + Lomb Corporation Common Shares ranks 29th of 141 in the group, against a group median of -0.18.